Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

47,250 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Physiological effect and therapeutic application of alpha lipoic acid.
Park S, Karunakaran U, Jeoung NH, Jeon JH, Lee IK. Park S, et al. Curr Med Chem. 2014;21(32):3636-45. doi: 10.2174/0929867321666140706141806. Curr Med Chem. 2014. PMID: 25005184 Review.
Dimethylfumarate attenuates restenosis after acute vascular injury by cell-specific and Nrf2-dependent mechanisms.
Oh CJ, Park S, Kim JY, Kim HJ, Jeoung NH, Choi YK, Go Y, Park KG, Lee IK. Oh CJ, et al. Among authors: park s, park kg. Redox Biol. 2014 Jun 24;2:855-64. doi: 10.1016/j.redox.2014.06.003. eCollection 2014. Redox Biol. 2014. PMID: 25009787 Free PMC article.
Activation of Nrf2 by dimethyl fumarate improves vascular calcification.
Ha CM, Park S, Choi YK, Jeong JY, Oh CJ, Bae KH, Lee SJ, Kim JH, Park KG, Jun do Y, Lee IK. Ha CM, et al. Among authors: park s, park kg. Vascul Pharmacol. 2014 Oct;63(1):29-36. doi: 10.1016/j.vph.2014.06.007. Epub 2014 Aug 16. Vascul Pharmacol. 2014. PMID: 25135648
Scoparone interferes with STAT3-induced proliferation of vascular smooth muscle cells.
Park S, Kim JK, Oh CJ, Choi SH, Jeon JH, Lee IK. Park S, et al. Exp Mol Med. 2015 Mar 6;47(3):e145. doi: 10.1038/emm.2014.113. Exp Mol Med. 2015. PMID: 25744297 Free PMC article.
Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation.
Choi SH, Park S, Oh CJ, Leem J, Park KG, Lee IK. Choi SH, et al. Among authors: park s, park kg. Vascul Pharmacol. 2015 Oct;73:11-9. doi: 10.1016/j.vph.2015.07.005. Epub 2015 Jul 15. Vascul Pharmacol. 2015. PMID: 26187356
Pyruvate Dehydrogenase Kinase 4 Promotes Vascular Calcification via SMAD1/5/8 Phosphorylation.
Lee SJ, Jeong JY, Oh CJ, Park S, Kim JY, Kim HJ, Doo Kim N, Choi YK, Do JY, Go Y, Ha CM, Choi JY, Huh S, Ho Jeoung N, Lee KU, Choi HS, Wang Y, Park KG, Harris RA, Lee IK. Lee SJ, et al. Among authors: park s, park kg. Sci Rep. 2015 Nov 12;5:16577. doi: 10.1038/srep16577. Sci Rep. 2015. PMID: 26560812 Free PMC article.
Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury.
Oh CJ, Ha CM, Choi YK, Park S, Choe MS, Jeoung NH, Huh YH, Kim HJ, Kweon HS, Lee JM, Lee SJ, Jeon JH, Harris RA, Park KG, Lee IK. Oh CJ, et al. Among authors: park s, park kg. Kidney Int. 2017 Apr;91(4):880-895. doi: 10.1016/j.kint.2016.10.011. Epub 2016 Dec 28. Kidney Int. 2017. PMID: 28040265
Role of the Pyruvate Dehydrogenase Complex in Metabolic Remodeling: Differential Pyruvate Dehydrogenase Complex Functions in Metabolism.
Park S, Jeon JH, Min BK, Ha CM, Thoudam T, Park BY, Lee IK. Park S, et al. Among authors: park by. Diabetes Metab J. 2018 Aug;42(4):270-281. doi: 10.4093/dmj.2018.0101. Diabetes Metab J. 2018. PMID: 30136450 Free PMC article. Review.
Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.
Lee D, Pagire HS, Pagire SH, Bae EJ, Dighe M, Kim M, Lee KM, Jang YK, Jaladi AK, Jung KY, Yoo EK, Gim HE, Lee S, Choi WI, Chi YI, Song JS, Bae MA, Jeon YH, Lee GH, Liu KH, Lee T, Park S, Jeon JH, Lee IK, Ahn JH. Lee D, et al. Among authors: park s. J Med Chem. 2019 Jan 24;62(2):575-588. doi: 10.1021/acs.jmedchem.8b01168. Epub 2019 Jan 9. J Med Chem. 2019. PMID: 30623649
Recent advances in the pathogenesis of microvascular complications in diabetes.
Park S, Kang HJ, Jeon JH, Kim MJ, Lee IK. Park S, et al. Arch Pharm Res. 2019 Mar;42(3):252-262. doi: 10.1007/s12272-019-01130-3. Epub 2019 Feb 15. Arch Pharm Res. 2019. PMID: 30771210 Review.
47,250 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback